NADIM trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

NADIM trial

Oct 18, 2024, 15:32 | Blog

Five year outcomes of Phase II NADIM trial, summarised by Jarushka Naidoo

Jarushka Naidoo shared a post on X: "5yr outcomes Ph II NADIM trial: - - 5yr…

Oct 16, 2024, 17:00 | Insight

Biagio Ricciuti: 5-year update from the NADIM trial

Biagio Ricciuti shared a post on X about a recent paper by Mariano Provencio et…

Jul 17, 2024, 01:52 | Blog

Estela Rodriguez: Mariano Provencio at ASCO Miami presenting history of perioperative chemoIO trials in lung cancer

Estela Rodriguez shared a post on X: . "What a treat to have Prof Mariano…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023